Axcelis Technologies, Inc. (ACLS) Q2 2025 Earnings Call Transcript

Axcelis Technologies (ACLS) reported strong Q2 2025 results, surpassing expectations with $195 million in revenue and non-GAAP EPS of $1.13, driven by robust 45.2% non-GAAP gross margins and a 20% adjusted EBITDA margin. While Q2 bookings were $96 million (0.8x book-to-bill) reflecting ongoing customer capacity digestion, the company noted slight improvement in H1 bookings versus H2 2024. Power applications, particularly silicon carbide, comprised most system shipments with firm China demand and R&D investments outside, while memory spending remained muted. Axcelis projects Q3 revenue of approximately $200 million, expecting modest H2 2025 revenue improvement primarily from power, and emphasized its resilient CS&I business (30% of H1 revenue), strong $581 million cash position, and opportunistic share repurchases as key to navigating the cyclical downturn and positioning for long-term growth.

Analysis

Axcelis Technologies reported strong Q2 2025 results, significantly outperforming guidance with revenue of $195 million and non-GAAP EPS of $1.13. The beat was primarily driven by exceptional non-GAAP gross margins of 45.2%, well above the 42% outlook, which management attributed to a favorable mix toward the high-margin Customer Solutions & Innovations (CS&I) business, disciplined cost control, and favorable systems mix. Despite this profitability, demand signals remain mixed, with bookings of $96 million leading to a book-to-bill ratio of 0.8x, indicating ongoing capacity digestion among customers. However, management noted that H1 2025 bookings showed a slight improvement over H2 2024. The power device market, particularly for silicon carbide applications, remains the primary driver of system shipments, with firm demand in China and R&D-focused investments in next-generation trench and super-junction technologies in other regions. In contrast, the general mature and memory segments remain weak, with spending muted for the balance of the year. The company's guidance for Q3 projects revenue of approximately $200 million and non-GAAP EPS of around $1.00, with an expected moderation in gross margins to 43% due to mix shifts. Axcelis is navigating the cyclical downturn by leveraging its resilient CS&I business, which now constitutes 30% of H1 revenue, and a strong balance sheet with $581 million in cash, enabling opportunistic share repurchases of $45 million in the quarter.

Key Decisions for Investors

• Investors should monitor the clear divergence between the resilient power segment, driven by secular silicon carbide trends, and the cyclically weak memory and general mature markets, as this bifurcation is key to the company's near-term performance.
• Given the sub-1.0 book-to-bill ratio, a return to broad-based growth hinges on a recovery in bookings, making this a critical metric to watch for signs that the industry is emerging from its capacity digestion phase.
• The company's ability to deliver robust gross margins and profitability during a downturn, supported by its high-margin CS&I business and strong cost controls, provides a significant defensive characteristic that should be considered in valuation.
• Long-term investors should note the strategic progress in penetrating next-generation power device technology, such as trench and super junction, which solidifies Axcelis's leadership in the high-energy implant market and positions it to capitalize on structural growth in EVs and AI-related power infrastructure.